StonvexLoading…
StonvexStonvexStonvexCore line items from ZG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $708.00M | $2.58B | $1.93B | $1.25B |
Operating Income | $36.00M | $-34.00M | $-23.00M | $-20.00M |
Net Income | $46.00M | $23.00M | $20.00M | $10.00M |
EPS (Diluted) | $0.19 | $0.09 | $0.08 | $0.04 |
Total Assets | $5.23B | $5.68B | $5.70B | $5.42B |
Total Liabilities | $818.00M | $801.00M | $706.00M | $670.00M |
Cash & Equivalents | $678.00M | $768.00M | $874.00M | $587.00M |
Free Cash Flow OCF − CapEx | $166.00M | $235.00M | $191.00M | $118.00M |
Shares Outstanding | 239.64M | 254.12M | 254.70M | 253.92M |